Abstract
C9H11N16K1O5, triclinic, P1Ì (no. 2), a = 7.983(2) Å, b = 9.731(2) Å, c = 12.300(4) Å, α = 84.689(9)°, β = 86.779(9)°, γ = 69.450(7)°, V = 890.5(4) Å3, Z = 2, Rgt(F) = 0.0396, wRref(F2) = 0.0878, T = 153 K.
Original language | English |
---|---|
Pages (from-to) | 679-680 |
Number of pages | 2 |
Journal | Zeitschrift fur Kristallographie - New Crystal Structures |
Volume | 231 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Sept 2016 |
Fingerprint
Dive into the research topics of 'Crystal structure of potassium (E)-5-oxo-4-((5-oxo-1H-1,2,4-triazol-4(5H)-yl)diazenyl)-4,5-dihydro-1,2,4-triazol-1-ide-(E)-4,4-diazene-1,2-diylbis(2,4-dihydro-3H-1,2,4-triazol-3-one)-methanol (1/1/1), C9H11N16KO5'. Together they form a unique fingerprint.Cite this
Zhao, B., Ge, Z., & Luo, Y. (2016). Crystal structure of potassium (E)-5-oxo-4-((5-oxo-1H-1,2,4-triazol-4(5H)-yl)diazenyl)-4,5-dihydro-1,2,4-triazol-1-ide-(E)-4,4-diazene-1,2-diylbis(2,4-dihydro-3H-1,2,4-triazol-3-one)-methanol (1/1/1), C9H11N16KO5. Zeitschrift fur Kristallographie - New Crystal Structures, 231(3), 679-680. https://doi.org/10.1515/ncrs-2015-0218